These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23709232)

  • 21. Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis.
    Mehta NN; Li R; Krishnamoorthy P; Yu Y; Farver W; Rodrigues A; Raper A; Wilcox M; Baer A; DerOhannesian S; Wolfe M; Reilly MP; Rader DJ; VanVoorhees A; Gelfand JM
    Atherosclerosis; 2012 Sep; 224(1):218-21. PubMed ID: 22858285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage cholesterol efflux correlates with lipoprotein subclass distribution and risk of obstructive coronary artery disease in patients undergoing coronary angiography.
    Linsel-Nitschke P; Jansen H; Aherrarhou Z; Belz S; Mayer B; Lieb W; Huber F; Kremer W; Kalbitzer HR; Erdmann J; Schunkert H
    Lipids Health Dis; 2009 Apr; 8():14. PubMed ID: 19348677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-Density Lipoprotein (HDL) Phospholipid Content and Cholesterol Efflux Capacity Are Reduced in Patients With Very High HDL Cholesterol and Coronary Disease.
    Agarwala AP; Rodrigues A; Risman M; McCoy M; Trindade K; Qu L; Cuchel M; Billheimer J; Rader DJ
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1515-9. PubMed ID: 25838421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HDL cholesterol efflux capacity and incident cardiovascular events.
    Rohatgi A; Khera A; Berry JD; Givens EG; Ayers CR; Wedin KE; Neeland IJ; Yuhanna IS; Rader DR; de Lemos JA; Shaul PW
    N Engl J Med; 2014 Dec; 371(25):2383-93. PubMed ID: 25404125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic risk factors for atherosclerosis in heart transplant recipients.
    Kemna MS; Valantine HA; Hunt SA; Schroeder JS; Chen YD; Reaven GM
    Am Heart J; 1994 Jul; 128(1):68-72. PubMed ID: 8017286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High- density lipoprotein function is abnormal in idiopathic inflammatory myopathies.
    Bae SS; Lee YY; Shahbazian A; Wang J; Meriwether D; Golub I; Oganesian B; Dowd T; Reddy ST; Charles-Schoeman C
    Rheumatology (Oxford); 2020 Nov; 59(11):3515-3525. PubMed ID: 32830270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally.
    Dhaliwal BS; Steinbrecher UP
    J Lipid Res; 2000 Oct; 41(10):1658-65. PubMed ID: 11013308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial Effects of Exercise-Based Cardiac Rehabilitation on High-Density Lipoprotein-Mediated Cholesterol Efflux Capacity in Patients with Acute Coronary Syndrome.
    Koba S; Ayaori M; Uto-Kondo H; Furuyama F; Yokota Y; Tsunoda F; Shoji M; Ikewaki K; Kobayashi Y
    J Atheroscler Thromb; 2016 Jul; 23(7):865-77. PubMed ID: 26947596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart failure is associated with impaired anti-inflammatory and antioxidant properties of high-density lipoproteins.
    Kim JB; Hama S; Hough G; Navab M; Fogelman AM; Maclellan WR; Horwich TB; Fonarow GC
    Am J Cardiol; 2013 Dec; 112(11):1770-7. PubMed ID: 24050409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis.
    Liao KP; Playford MP; Frits M; Coblyn JS; Iannaccone C; Weinblatt ME; Shadick NS; Mehta NN
    J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25637346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia.
    Martinez LR; Santos RD; Miname MH; Deus DF; Lima ES; Maranhão RC
    Metabolism; 2013 Aug; 62(8):1061-4. PubMed ID: 23540443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesterol efflux capacity, carotid atherosclerosis, and cerebrovascular symptomatology.
    Doonan RJ; Hafiane A; Lai C; Veinot JP; Genest J; Daskalopoulou SS
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):921-6. PubMed ID: 24558111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
    Zhang B; Bai H; Liu R; Kumagai K; Itabe H; Takano T; Saku K
    Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study.
    Saleheen D; Scott R; Javad S; Zhao W; Rodrigues A; Picataggi A; Lukmanova D; Mucksavage ML; Luben R; Billheimer J; Kastelein JJ; Boekholdt SM; Khaw KT; Wareham N; Rader DJ
    Lancet Diabetes Endocrinol; 2015 Jul; 3(7):507-13. PubMed ID: 26025389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired antioxidant HDL function is associated with premature myocardial infarction.
    Distelmaier K; Wiesbauer F; Blessberger H; Oravec S; Schrutka L; Binder C; Dostal E; Schillinger M; Wojta J; Lang IM; Maurer G; Huber K; Goliasch G
    Eur J Clin Invest; 2015 Jul; 45(7):731-8. PubMed ID: 25989880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOA1 oxidation is associated to dysfunctional high-density lipoproteins in human abdominal aortic aneurysm.
    Martínez-López D; Camafeita E; Cedó L; Roldan-Montero R; Jorge I; García-Marqués F; Gómez-Serrano M; Bonzon-Kulichenko E; Blanco-Vaca F; Blanco-Colio LM; Michel JB; Escola-Gil JC; Vázquez J; Martin-Ventura JL
    EBioMedicine; 2019 May; 43():43-53. PubMed ID: 30982767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of cholesterol uptake capacity, a novel indicator for HDL functionality, and coronary plaque properties: An optical coherence tomography-based observational study.
    Oshita T; Toh R; Nagano Y; Kuroda K; Nagasawa Y; Harada A; Murakami K; Kiriyama M; Yoshikawa K; Miwa K; Kubo T; Iino T; Nagao M; Irino Y; Hara T; Shinohara M; Otake H; Shinke T; Nakajima K; Ishida T; Hirata KI
    Clin Chim Acta; 2020 Apr; 503():136-144. PubMed ID: 31972150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein.
    Smith JD
    J Clin Lipidol; 2010; 4(5):382-8. PubMed ID: 21076633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CC-Chemokine Ligand 2 (CCL2) Suppresses High Density Lipoprotein (HDL) Internalization and Cholesterol Efflux via CC-Chemokine Receptor 2 (CCR2) Induction and p42/44 Mitogen-activated Protein Kinase (MAPK) Activation in Human Endothelial Cells.
    Sun RL; Huang CX; Bao JL; Jiang JY; Zhang B; Zhou SX; Cai WB; Wang H; Wang JF; Zhang YL
    J Biol Chem; 2016 Sep; 291(37):19532-44. PubMed ID: 27458015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antioxidant properties of high-density lipoproteins are impaired in women with polycystic ovary syndrome.
    Zhang J; Zhang Y; Liu H; Bai H; Wang Y; Jiang C; Fan P
    Fertil Steril; 2015 May; 103(5):1346-54. PubMed ID: 25813288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.